Acetazolamide reduces AMS risk by 31% but females face 4.8-fold higher risk of side effects
Acetazolamide helps prevent mountain sickness but causes more side effects in women
This randomized clinical trial of 303 healthy residents found that acetazolamide 125 mg twice daily reduced AMS incidence by 31% compared to…
Acetazolamide reduces mountain sickness risk, but women in a new study faced much higher rates of moderate to severe side effects.
Carbonic anhydrase inhibitors and DEXi show superior CMT reduction in retinitis pigmentosa macular oedema
New Analysis Compares Treatments for Retinitis Pigmentosa Macular Oedema
This network meta-analysis evaluates various treatments for retinitis pigmentosa (RP)-associated macular oedema. The study found that carbon…
Different medications show varying success in reducing swelling and improving vision for patients with retinitis pigmentosa-associated macul…
Narrative review guideline distinguishes episodic ataxia types using clinical features in limited resource settings
Clinicians can distinguish two rare ataxia types using specific symptoms and triggers
This narrative review guideline addresses episodic ataxia types 1 and 2 in limited resource settings where genetic testing is unavailable.
A review suggests doctors in areas with limited testing can tell apart two rare ataxia conditions by looking at attack duration and unique s…